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a b s t r a c t
This report describes the case of a woman with systemic lupus erythematous (SLE) that 
developed rhabdomyolysis after being infected by dengue virus. There are only a few cases 
of SLE accompanied by rhabdomyolysis, none of them associated with dengue fever.
Initially, the woman presented high fever, myalgia, muscular weakness, mild headache, 
polyarthralgia and thrombocytopenia reminding a lupus flare, but since the number of 
people infected by dengue at that time was high and the symptoms from both conditions 
are similar, a dengue serology was requested. After a few days, the patient developed 
rhabdomyolysis. She was then submitted to immunosuppressive drugs, urinary alkalization 
and vigorous hydration, which improved her muscle damage and inflammatory condition. 
The positive dengue serology was only available after the therapy above had been 
established. She was discharged in an asymptomatic state.
This case demonstrates how alike dengue fever and a lupus flare are, warning clinicians 
that, especially during an epidemic, both diseases should be carefully differentiated in 
order to establish a correct and efficient therapy.
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All rights reserved.
* Corresponding author.
E-mail: louiseverdolin@hotmail.com (L.D. Verdolin).
0482-5004/$ - see front matter. © 2014 Sociedade Brasileira de Reumatologia. Published by Elsevier Editora Ltda. All rights reserved.
http://dx.doi.org/10.1016/j.rbr.2013.02.003
A rabdomiólise está associada à febre dengue em um paciente lúpico
Palavras-chave:
Rabdomiólise
Febre dengue
Lúpus eritematoso sistêmico
r e s u m o
Esse relato descreve o caso de uma mulher com lúpus eritematoso sistêmico (LES) que 
sofreu rabdomiólise em seguida à sua infecção pelo vírus da dengue. Foram relatados ape-
nas alguns casos de LES com manifestação de rabdomiólise, nenhum deles associados à 
febre dengue. 
A princípio, a paciente apresentava-se com febre alta, mialgia, astenia muscular, leve cefa-
leia, poliartralgia e trombocitopenia, lembrando uma exacerbação lúpica, mas consideran-
do que o número de pessoas infectadas pela dengue na época era alto e tendo em vista que 
os sintomas das duas condições são parecidos, foi solicitada sorologia para dengue. Trans-
corridos alguns dias, a paciente apresentou rabdomiólise, tendo então sido tratada com 
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medicamentos imunossupressivos, alcalinização urinária e hidratação vigorosa, medidas 
que melhoraram seus danos musculares e a condição inflamatória. A sorologia positiva 
para dengue nos foi disponibilizada apenas depois da instauração do tratamento descrito 
acima. A paciente recebeu alta em estado assintomático.
Esse caso demonstra a grande semelhança entre a febre dengue e uma exacerbação lúpi-
ca; isso deve alertar o clínico para que, especialmente durante uma epidemia, faça uma 
cuidadosa diferenciação entre essas doenças, de forma a estabelecer uma terapia correta 
e eficiente.
© 2014 Sociedade Brasileira de Reumatologia. Publicado por Elsevier Editora Ltda. 
Todos os direitos reservados.
Table 1 – Laboratory results
Admission Day 5 Day 9 Day 19 Discharge
Hemoglobine (g/dL) 13.7 10.3 10.1 8.9 10.3
Hematocrit (%) 42.4 30.3 31.5 27.4 32.2
Platelets (per mm3) 60,000 36,000 101,000 244,000 254,000
Leukocytes (per mm3) 29,500 10,000 11,000 8,400 9,500
Glucose (mg/dL) 85 95 90 65 N.M.
Urea (mg/dL) 27 24 34 25 34
Creatinine (mg/dL) 0.91 0.73 0.55 0.81 0.61
Albumine (g/dL) 3.0 2.6 2.2 3.1 N.M.
Globuline (g/dL) 3.6 3.7 3.0 3.4 N.M.
AST (U/L) 140 6,601 4,679 352 121
ALT (U/L) 62 1,115 1,325 422 136
Calcium (mg/dL) 7.1 7.1 7.0 8.5 8.9
Sodium (mEq/L) 134 136 138 138 138
Potassium (mEq/L) 3.3 4.2 4.4 3.3 4.0
CRP (mg/dL) 1.06 1.32 4.84 1.51 N.M.
ESR (mm/h) 25 53 51 38 N.M.
CK (U/L) N.M. A.U.L 45,265 9,117 2,681
AST, aspartate aminotransferase; ALT, alanine aminotransferase; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; CK, creatine 
kinase; N.M., not measured; A.U.L., above upper limit.
Introduction
From the first semester of 2011 to the first week of October 
2011, there were 721,546 reported cases of dengue in Brazil.1 
Dengue fever is an arbovirus that typically manifests high 
fever, severe myalgia, arthralgia, headache, retro-orbital 
pain, and rash. Rare clinical manifestations include hepati-
tis, rhabdomyolysis and neurological presentations, such as 
encephalopathy, peripheral neuropathy, and Guillain-Barré 
syndrome.2 Rhabdomyolysis is a disorder characterized by 
skeletal muscle injury, associated with the extravasation of 
intracellular constituents into the plasma, resulting in elec-
trolyte disorders and even acute kidney injury.3
Symptoms such as fever, thrombocytopenia, or arthral-
gia are found in many diseases, including SLE, which is an 
inflammatory autoimmune disorder characterized by peri-
ods of remissions and relapses. Epidemiological studies of 
incidence and prevalence of SLE are scarce in Brazil, where 
high racial miscegenation and different weather condi-
tions can influence the disease’s complications. In Brazil, 
lupus is more common in the black population than any 
other. Within the entire Brazilian population, lupus affects 
women of reproductive age more than men, with a ratio of 
9-10:1.4
A new infection by dengue virus in patients with previ-
ous diagnosis of lupus may mimic its reactivation.5 There 
have been a few reports illustrated in the literature of rhab-
domyolysis in lupic patients and in other patients infected by 
dengue fever,2,6 but there are no cases combining all of these 
conditions: lupus, dengue and rhabdomyolysis together. Our 
objective is to describe the case of a patient previously diag-
nosed with lupus that manifested rhabdomyolysis secondary 
to dengue fever.
Case report
In 2010, a thirty-nine year-old black woman developed malar 
rash, photosensitivity, oral ulcers and polyarthritis; she was 
diagnosed with SLE. At that time, her antinuclear antibody 
was 1/160 with a fibrillar cytoplasmic pattern, and she was 
treated with prednisone, azathioprine and hydroxicloroquine. 
Her symptoms resolved. However, in the first semester of 2011, 
she was admitted to the emergency room of a university hos-
pital with high fever (39 degrees Celsius), chills, myalgia, mus-
cular weakness, mild headache and polyarthralgia (shoul-
ders, elbow, wrists, hips and knees). Her admission exams 
(Table 1) showed thrombocytopenia (60,000 per mm3), high 
C reactive protein (CRP), leukocytosis without neutrophilia, 
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hypoalbuminemia, erythrocyte sedimentation rate (ESR) dis-
cretely elevated, high liver enzymes [aspartate transaminase 
(AST) higher than alanine transaminase (ALT)]. Complement 
levels were in the inferior normal range. Antibodies to Deoxy-
ribonucleic Acid (anti-DNA), anti-SSB/La, anti-Smith and an-
tibodies to nuclear ribonucleoproteins (anti-RNP) were in the 
normal range. Urine analysis revealed proteinuria (30mg/dL). 
Dengue serology was requested upon admission, due to an 
epidemiologic suspicion: it was summer time in Rio de Janei-
ro, and there were a lot of patients affected by this arbovirus. 
She was medicated with symptomatic medications.
Five days after admission her symptoms worsened, and 
she manifested muscular weakness, red urine (Urine analy-
sis: pH 8,5, density 1,015, false positive for hemoglobinuria 
(+++) without erythrocytes, no evidence of erythrocyte di-
morphism; 24-hour urine collection revealed 4,681.46mg of 
proteinuria) and increased edema, more pronounced in the 
arms. Creatine kinase (CK) was much higher than the upper 
limit detection rate of our test (dimension RXLMAX clinical 
chemistry system from Siemens, USA). The muscle injury was 
so elevated that four days passed before this enzyme could be 
detected, at which time it had reached a level of 45,265 (U/L). 
She also presented high AST (6,601U/L) and ALT (1,115U/L), 
hypocalcemia (7.1mg/dL), and metabolic acidosis, but electro-
lytes and renal function were still normal. Rhabdomyolysis 
was diagnosed and urinary alkalization plus vigorous hydra-
tion were started.
After 48 hours, the patient evolved with clinical and labo-
ratory deterioration. She manifested generalized edema, now 
much worse on her lower limbs, making it difficult to palpate 
the leg’s arterial pulses. Compartmental syndrome was sus-
pected, and it was decided to submit her to pulse therapy 
with methylprednisolone (1g per day for three days). At this 
point, lupus flare was the main hypothesis for rhabdomy-
olysis. Only after administration of the pulse therapy was 
the dengue serology result available. IgM antibody was 20.38 
Panbio (ELISA). Levels above 11 Panbio suggest recent dengue 
infection. Hepatitis virus and HIV serology were all negative. 
Urinary alkalization and vigorous hydration were maintained 
and symptoms improved. After 34 days in hospital, the patient 
was discharged and sent home with a supply of chloroquine, 
prednisone and azathioprine. At this moment, her laboratory 
exams showed improvement: liver enzymes were dropping 
(AST: 121U/L, ALT 136U/L), and her CK levels (2,681U/L) de-
creased 94.07% from the highest measurable value. She had 
no clinical symptoms.
Discussion
Several conditions may lead to rhabdomyolysis, such as trau-
ma, drugs, genetic disorders, endocrine, metabolic and infec-
tious diseases.3 This condition is rarely described in rheuma-
tologic diseases. Six cases of rhabdomyolysis in lupic patients 
have been reported in the literature: two of them had discoid 
lupus, and four had SLE. The precipitating factors responsible 
for the induction of rhabdomyolysis in three of these patients 
were: the use of myotoxic drugs in one case and bacterial in-
fection in two cases. In the remaining cases, no precipitating 
factors were identified.6
When the patient arrived at the hospital, the first hypoth-
esis was lupus reactivation, since her main complaint was ar-
thralgia and her laboratory exams showed thrombocytopenia, 
with high CRP. After the positive serology for dengue was re-
ceived, it was clearer the infection was the precipitating factor 
for the rhabdomyolysis. The clinical manifestations of dengue 
and lupus flare may be similar, and this may confound physi-
cians. However, in a review of Medline’s database, only a few 
reports of dengue mimicking a lupus flare were found.5 
It is important that, in countries where dengue is a com-
mon disease, clinicians carefully distinguish a lupus flare 
from a dengue infection. In this case, the epidemiology of 
dengue (summer time and the high number of infection cases 
at the time) was the leading clue to request the serology.
Evidence suggests that bacterial and viral infection could 
become a trigger for a new or relapsing lupus flare in geneti-
cally predetermined individuals. This has been proven, for 
example, in Cytomegalovirus infection. Studies show that Ep-
stein-Barr virus infection presents immunologic aberrations 
of B cells and apoptosis and molecular mimicry that perpetu-
ate autoimmunity in SLE.7 There are no studies proving a re-
lationship between dengue and SLE, but recently there has 
been a report which considers the possibility of dengue virus 
triggering a dysfunctional immune response resulting in the 
development of autoimmunity and SLE with lupus nephritis.8 
In the literature, there are no reports of rhabdomyolysis as-
sociated with dengue fever in a lupic patient.
Viruses that commonly cause rhabdomyolysis are influen-
za A and B, HIV, Coxsackie and Epstein-Barr.3 Dengue shares 
several features with these viruses, and there have been few 
cases of dengue with rhabdomyolysis.9 There is no proved 
cause for this association, but some hypotheses have been 
proposed. Direct viral invasion of the muscle had not been 
demonstrated, but some muscle biopsies showed marked in-
flammation, varying from mild lymphocytic infiltrate to foci 
of severe myonecrosis. Myotoxic cytokines, especially TNF 
released in response to virus infection, may have been the 
cause of the muscle injury.10-12
In the case reports describing rhabdomyolysis due to 
dengue, patients were treated with urinary alkalization and 
vigorous hydration, with favorable outcome in one case and 
death in the other.9 The patient described in our case was in-
fected with a viral disease, but initially she was treated with 
pulse therapy with methylprednisolone because her clinical 
deterioration was attributed to lupus exacerbation. The den-
gue serology was only released after this treatment was es-
tablished. Her clinical outcome was favorable. 
No specific treatment for dengue exists, apart from analge-
sia and medications to reduce fever.2 In this case, methylpred-
nisolone was used because of the suspicion that the patient 
was clinically deteriorating due to a lupus flare. Some authors 
argue there is no evidence in vivo to support the use of an-
tiviral agents, drugs that reduce vascular permeability, nor 
corticosteroid, and that high-dose methylprednisolone fails 
to reduce mortality in severe dengue shock syndrome (DSS).13 
Others suggest that a single dose of intravenous methyl pred-
nisolone, 1g intravenous over 20 min as rescue medication to 
highly selected patients who develop hypotensive DSS, reduc-
es mortality (p=0.01).14 Nevertheless, the author of this article 
emphasizes the importance of randomized clinical trials to 
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confirm this fact. Regarding the rhabdomyolysis treatment, 
there is only one case reporting that steroid therapy should be 
considered for the treatment of rhabdomyolysis or myopathy 
associated with Cytomegalovirus infection in order to prevent 
renal failure or fatal progression of the disease.15 Therefore it 
is impossible to know if the steroids used in the patient had 
any influence in her outcome, since there are no clinical trials 
available addressing this specific case.
Conclusion
There are few cases of SLE manifesting rhabdomyolysis, none 
of them previously associated with dengue fever as described 
in our case report. Although rhabdomyolysis is an uncommon 
presentation of this viral infection, dengue fever clinical mani-
festations may mimic lupus flare. Rheumatologists, clinicians 
and infectologists should be aware of common manifestations 
of these diseases in order to identify more severe cases.
Acknowledgments
Michele Veldhoen.
Conflicts of interest
The authors declare no conflict of interest.
R E F E R E N C E S
1. Coordenação Geral do Programa Nacional de Controle da 
Dengue. Balanço Dengue: Semana Epidemiológica 1 a 39 
de 2011 [Internet]. 2011 [accessed in 11 November 2011]. 
Available at: http://portal.saude.gov.br/portal/arquivos/pdf/
informe_dengue_2011_37_39.pdf. 
2. Karakus A, Banga N, Voorn GP, Meinders AJ. Dengue shock 
syndrome and rhabdomyolysis. Neth J Med. 2007;65:78-81.
3. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney 
injury. New Engl J Med. 2009;361:62-72.
4. Nakashima CAK, Galhardo AP, Silva JFPM, Fiorenzano 
GR, Santos ABS, Leite MFS, Nogueira MA et al. Incidence 
and clinical-laboratory aspects of systemic lupus 
erythematosus in a southern Brazilian city. Rev Bras 
Reumatol. 2011;51:231-39.
5. Souza SP, Moura CGG. Dengue mimicking a lupus flare. J 
Clin Rheumatol. 2010;16:47-78.
6. Carvalho JF, Mota LM, Bonfa E. Fatal rhabdomyolysis 
in systemic lupus erythematosus. Rheumatol Int. 
2010;31:1243-5.
7. Zandman-Goddard G, Shoenfeld Y. Infections and SLE. 
Autoimmunity. 2005;38:473-85.
8. Rajadhyaksha A, Mehra S. Dengue fever evolving into 
systemic lupus erythematosus and lupus nephritis: a 
case report. Lupus [Internet]. 2012 [accessed in 8 March 
2012]; 0:1-4. Available at: http://lup.sagepub.com/content/
early/2012/02/21/0961203312437807.
9. Davis SJ, Bourke P. Rhabdomyolysis associated with dengue 
virus infection. Clin Infect Dis. 2004;38:109-11.
10. Halstead SB. Dengue. Curr Opin Infect Dis. 2002;15:471-6.
11. Konrad RJ, Goodman DB, Davis WL. Tumor necrosis factor and 
coxsackie B4 rhabdomyolysis. Ann Intern Med. 1993;119:861.
12. Gagnon S, Mori M, Kurane I. Cytokine gene expression and 
protein production in peripheral blood mononuclear cells 
of children with acute dengue virus infections. J Med Virol. 
2002;67:41-6.
13. Rigau-Perez JG, Clark GC, Gubler DJ, Reiter P, Sanders EJ, 
Vorndam AV. Dengue and dengue haemorrhagic fever. Lancet. 
1998;352:971-7.
14. Premaratna R, Jayasinghe KG, Liyanaarachchi EW, 
Weerasinghe OM, Pathmeswaran A, Silva HJ. Effect of a 
single dose of methyl prednisolone as rescue medication for 
patients who develop hypotensive dengue shock syndrome 
during the febrile phase: a retrospective observational study. 
Int J Infect Dis. 2011;15:433-4.
15. Sato K, Yoneda M, Hayashi K, Nakagawa H, Higuchi 
I, Kuriyama M. A steroid-responsive case of severe 
rhabdomyolysis associated with cytomegalovirus infection. 
Rinsho Shinkeigaku. 2006;46:312-6.
